| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0ad22ae5cf06740d4ecd9437923ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07029c798739b407c1d8cfaa18851dde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_931bbd38121ff3ae63a25c4ae56e99b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e346c7d2f5798b3908adc86f8752137 |
| publicationDate |
2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3700935-A1 |
| titleOfInvention |
Drug-induced activation of the reelin signaling system |
| abstract |
The invention provides compounds for activating the REELIN signaling system for the treatment of neurological disorders. The invention further provides compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR. |
| priorityDate |
2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |